Simple Summary: In the current study, we hypothesized that the in ovo injection of L-arginine (LArg) at different stages of embryonic development which would have positive effects on survival rate, hatching rate, immunoglobulin (IgM) levels and heat shock proteins such as HSP-47, 60 and 70 as well muscle development markers mainly myoD and myogenin. As indicated, the in ovo injection of L-Arg resulted in increased hatch rate and weight, survival rate, higher levels of IgM, and myogenin and MyoD expression in the muscles. At the same time, a decrease in the level of HSP-47,60 and 70 expressions in the tissues at 14 th day of injection compared to 8 th and 18 th day of injection peroid. In addition, the in ovo injection of L-Arg decreased the SGOT and SGPT concentration in serum as well micronuclei and nuclear abnormality in the blood of 14 th day incubation period. Hence, 14 th day would be suitable day for injection of L-Arg to promote the hatching rate and muscle growth of broiler chickens (i.e. animals).
Introduction
Selection of chickens (Gallus gallus) for meat production has led to the generation of inbred strains that show accelerated growth performance, particularly enhanced muscle growth that mostly occurs during embryogenesis [1, 2] . During embryogenesis, nutrients and energy are mainly getting from yolk mainly containing lipids and low level of carbohydrates [3] . Subsequently, the embryo and post-hatch chicken depends up on gluconeogenesis from essential amino acids [4, 5] . In recent years, found that administration of amino acids into fertilized broiler eggs called in ovo feeding may provide poultry companies with an alternative method to increase hatchability and muscle growth weight of newly hatched chick [6, 7] . Supplementation of nutrients into fertilized broiler egg influences the growth and embryo development during incubation and post-hatch growth performance of chickssampling procedures complied with the "Guidelines on Ethical Treatment of Experimental Animals" (2015) No. CBNU 2015-048 set by the Ministry of Science and Technology, Republic of Korea.
Chemicals
L-arginine was purchased from Sigma-Aldrich (Sigma-Aldrich, St. Louis, MO, USA). iScriptTM cDNA synthesis kit (170-8891) and SsoFast Eva-Green Supermix (172-5202) were purchased from BIO-RAD (BIO-RAD Laboratories, Inc., Hercules, CA, USA). Chemiluminescent for band detection purchased from Thermo Scientific (Rockford, IL, USA). Antibodies were purchased from ENZO Life Science (Farmingdale, NY, USA). Hematoxylin and eosin (H&E)1 were purchased from SigmaAldrich (St. Louis, MO, USA). All laboratory glassware was acquired from Falcon Lab ware (Becton, Dickinson and Company, Franklin Lakes, NJ, USA).
Experimental Design and Incubation
Ross 1040 broiler chicken eggs were obtained from Samhwa-Won Jong, South Korea. On the 1 st day of incubation, eggs were weighed (60 ± 1.36 g) and separated to different groups. Eggs were randomly divided into thirteen groups (4 × 20 × 3 = replication × eggs × injection) detail described in in followings. L-Arg was injected at three concentrations (100 µg, 1,000µg, and 2,500µg/100µl/egg) at 8 th , 14 th , and 18 th day of incubation period, respectively. A 0.100 mL of L-Arg solution (dissolved in 1% PBS) was injected into the air sac of egg. Immediately after the injection, the hole was sealed with liquid paraffin. Eggs were then placed in an incubator for 20 days under standard conditions (temperature, 37.8°C; humidity, 60%). On the 18 th day, eggs were transferred to hatching boxes and promptly placed in a hatcher incubator with humidity maintained at 60% and temperature set at 37°C to hatch chicks. At the end of the rearing period, the one day old chicks were sacrificed by cutting the jugular and carotid veins, after which further slaughter processing was conducted. During the slaughter process, 2 mL of blood as well as tissue from the breast muscle were collected and washed in ice-cold saline. Small amount of collected blood were immediately smeared on clean grease free microscope slides and air-dried for Micronuclei (MN) and Nuclear Abnormality. 
In ovo injection and treatment groups

Group
Survival rate measurement
Embryos' survival rates during the incubation period were measured on the 8 th day. Treated eggs were checked to determine the number of live and dead eggs as well as fertilized and nonfertilized ones among the total number of eggs. At 18 th day of incubation, after injection the eggs live eggs were moved to another hatching incubator with their respective experimental group. Survival rate was calculated with the following equation:
Hatching rate, body weight, and liver weight measurements
On the 21 st day, hatched chicks were moved from the hatcher incubator to hatching boxes to determine hatching rates. These hatched chicks were kept without feed and water at 32 °C. They were then weighed to record their live body weights and liver weights. The hatching rate was calculated with the following formula:
Biochemical indices
On the 21 st day of the post hatching period, chicks were sacrificed under anesthesia (diethyl ether). Blood was collected from the jugular vein into tubes containing ethylenediaminetetraacetic acid (EDTA) for serum separation. Liver samples were excised, washed with ice-cold saline, weighed, and then homogenized with cold 0.1 M phosphate buffer, pH 7.4. Concentrations of serum glutamicoxaloacetic transaminase (SGPT) and serum glutamic-pyruvic transaminase (SGOT) in sera were measured using commercial kits (Asan Pharamaceuticals Co., Ltd., Seoul, South Korea).
Micronuclei (MN) and nuclear abnormality (NA) tests using periodic acid Schiff's (PAS) staining
Blood samples collected from the first day of hatching period were immediately smeared on clean grease-free microscope slides and air-dried. Afterwards, slides were fixed with methanol for 5 min at room temperature, gently rinsed with running tap water for 1 min, and immersed in a periodic acid solution for 5 min at room temperature. These slides were then rinsed using D.H2O, immersed in PAS Schiff's reagent for 15 min at room temperature, and gently washed with running tap water for 5 min. Finally, counter-staining was performed with a hematoxylin solution for 90s. Slides were then rinsed in running tap water for 30 s, air dried, and examined with a light microscope (100X) using mineral oil.
Measurement of IgM concentration in plasma
Plasma samples were collected from individual experimental animals to determine plasma immunoglobulin (Ig) M levels using chicken IgM ELISA kit (Abcam) following the manufacture's specification. IgM levels were analyzed based on absorbance values measured at 450 nm.
Analysis of heat-shock proteins (HSPs) by western blot
Proteins were extracted from 100 mg of muscle samples using radioimmunoprecipitation assay (RIPA) buffer to determine protein expression levels of HSP-47, HSP-60, HSP-70, myoD and myogenin in experimental groups. Protein concentrations were determined using a BIO-RAD protein assay kit (BIO-RAD). Extract samples containing 50 µg of protein were solubilized in Laemmli buffer, separated by 12% acrylamide gel, and then transferred to Hybond-P PVDF membranes (GE Healthcare Inc., Amersham, UK) for 60 min at 200 mA. These PVDF membranes were then blocked with 5% skimmed milk powder in 0.5 M Tris-buffered saline (pH 7.4) with 0.05% Tween 20 (TBST) at room temperature for 2 h. Western immunoblotting with HSP-47, HSP-60, HSP-70, Myo-D and Myogenin are primary antibodies (1:2500 dilution) took place overnight. After washing three times with TBST, these membranes were probed with HRP-conjugated secondary antibodies (1:5000 dilutions) for 60 min at room temperature and then washed thrice with TBST (10 min each wash). Protein bands were visualized using a Chemiluminescent assay kit from Thermo Scientific for 1 to 5 min. Bands were imaged with an iBright™ CL1000 Imaging System (Invitrogen) and quantified using Image J Software. Relative density of band was normalized to that of β-actin as an internal control.
In silico molecular docking studies
To understand the mechanism of interaction of L-Arg with heat shock protein, crystal structures of GroEL mutant A109C (PDB ID: 5OPW) [22] and human HSP70 substrate binding domain L542Y mutant (PDB ID: 5XIR) [21] were downloaded from protein data bank. Molecular docking studies were performed using the GLIDE program [23] (version 8.5, Schrodinger LLC, New York, NY, USA). To analyze docking results and execute the protocol, the Maestro user interface (version 8.5, Schrodinger LLC, New York, NY) was employed. Validation of the protocol was performed by redocking. The structure of L-Arg was sketched using ACD/chemsketch (Freeware version). GLIDE grid generation wizard was used to define the docking space. Docking was performed using XP (Extra Precision mode) docking protocol.
Histopathological Study of the Liver
Livers were collected after chickens were sacrificed, immediately fixed with 10% neutral buffered formalin (NBF), and processed in an auto processor (Excelsior ES, Thermo Scientific, Waltham, MA, USA). After embedding in paraffin, 5 μm sections were made and subjected to H&E staining. Digital images were obtained using a Leica DM2500 microscope (Leica Microsystems, Wetzlar, Germany) at fixed 100 × (200×) magnification.
Statistical analysis
Data were analyzed using Tukey's HSD test post-hoc following ANOVAs with SAS® software, version 9.4. Student's t-tests were used to determine statistical differences between groups. Values are presented as mean ± SD from twelve determinations.
Results and discussion
Survival rate and hatchability
Survival rate was significantly (p < .05) increased in 2T1 and 3T1 groups than that in other groups. The lowest survival rate was observed in 1T3, 3T2, and 3T3 groups. There was no difference among the IC, IC1, 2C1 and 3C1. These results showed that the survival rates were differed depending upon the injection period and the concentration of L-Arg. Embryos may utilize in ovo administered amino acids to improve energy status and save muscle protein to improve enteric development, hatching, and survival rate [24] . In our study, the same mechanism might have occurred administration of L-Arg could improve the survival rate at the minimal concentration (3T1) of 14 th day injection period (Figure 1 ). However, during incubation, excess of amino acids such as glycine and proline failed to the embryo development [25] . The same attributes could have been in our current study that maximum concentration of L-Arg affect the embryonic growth.
Different concentration of L-Arg injected in embryos which can influence biological molecules and toxicity during embryogenesis. However, several studies have reported that higher doses of LArg become toxic which can cause significantly increased mortality rates and impaired weight gain. Lower concentration of L-Arg (1.0%) injected chicks showed better growth performance than higher concentration (1.5%) of L-Arg injected chicks [25] . The parallel effect revealed in our current study, that lower concentration of L-Arg (2T1) at 14 th day injection can increase hatching rate (96.29%), body weight (64.25g) also increased the survival rate (98.03%) compared to other groups ( Figure 1 , Figure  2 & Figure 3 ). The in ovo injection of L-Arg to late term embryos can increase the body weight (5 to 6%) compared to controls [5] . In addition, in ovo administration of all 20 different amino acids can increase chick weight by 3.6% and 2.1%, respectively [10] . The in ovo administration of amino acids might have stimulated utilization of amino acids with concomitant decrease in degradation of amino acids by the embryo [26] . In-ovo feeding of L-Arg resulted in higher embryo weight. This might be due to increase in muscle mass known to be affected by administration of in-ovo feeding. It has been reported that L-Arg could stimulate muscle development [27] . Thus, in-ovo injected L-Arg could be utilized by the embryo, resulting in increased muscle mass and heavy embryo that can increase the hatching rate [28] . L-Arg may attenuate adverse effects of rearing chickens under cold ambient temperatures or at high altitudes. Furthermore, feeding broiler chickens with diet that is deficient of L-Arg under cold stress at high altitudes can depress nitric oxide synthesis, decrease feed intake, reduce body weight gain, increase right ventricle to total ventricle weight ratio, mortality rate, and ascites mortality [29] . Previous study reported that lower percentage (1.36%) of L-Arg supplemented to broiler easily digestible than higher percentage of arginine, and it could obtain the highest egg weight [30] . Albeit, the low dose of L-Arg stimulates the secretion of the growth hormone could be increased the body weight [21] . The same mechanism might be occurred in our present study, L-Arg appeared to improve body weight of chicks in group 2T1 (Figure 3 ). However, body weights did not significantly vary among other groups. Hence, low dose (2T1) of L-Arg injected on the 14 th day incubation period could improve body weight compared to 8 th and 18 th day of incubation period. 
Biochemical indices (SGOT and SGPT)
Elevated SGOT and SGPT levels which indicates improper liver functions due to damages of cell integrity and cell membrane in liver. Our results revealed that injection of L-Arg at all doses except lower dose which has affected SGOT and SGPT levels at 8 and 18 th day embryonic stages (Figure 6a ). SGOT and SGPT levels were significantly decreased in 2T1 and 2T2 groups of embryos compared to those in other groups. There was no difference among the IC, IC1, 2C1 and 3C1. Increased levels of SGOT and SGPT in the blood are conducive to liver function damage [31] . In fact, free radicals can attack hepatocytes and release stored ALT to re-enter the blood serum [32] . Lower concentration of L-Arg supplementation caused greater percentage reduction in SGOT and SGPT levels in sickle cell anaemia subjects [31] . Supplementation of L-Arg to mice with higher concentration showed increased the SGOT and SGPT levels had been linked to damage to hepatic cells and hemolysis [33] . The cause of liver damage is unclear. Hence, confirming that higher concentration of L-Arg might have damaged the hepatic cell through elevation of SGOT and SGPT in 1T1, 1T2, 1T3, 3T1, 3T2 and 3T3 group. Other hand 2T1 group of injected chicken embryos could re-back the SGOT and SGPT levels compared to the other groups. Stimulating action of nitric oxide (NO) production by L-Arg results showed that improved the degree of the heapto-cellular structure by blocking of Bcl-2 and Tumor necrosis factor-α (TNF-α) [34] . In addition, L-Arg at 1g/day decreased the liver enzymes such as SGOT and SGPT through increased the sitric oxide (NO) synthesis. NO synthase plays an important role in liver injury through Inducible Nitric Oxide Synthase (iNOS) pathways [35] . The same mechanism could be involved in our curent study too.This same mechanism would be occurred in our study that the production of NO reduces necrosis and apoptosis by attenuation of inflammatory pathway to prevent the hepatotoxicity, improved the hepatobiliary function and the ultrastructure of liver results reduced the SGOT and SGPT levels in L-Arg treatment in the lower dose (2T1) at 14 th day injection of embryos ( Figure 4 ). 
Micronuclei (MN) and nuclear abnormality (NA) tests using periodic acid Schiff's (PAS) staining
The wide use of different doses of L-Arg at three different incubation period requires to examine the genotoxic activity in peripheral blood [36] . MN and NA tests were conducted to examine peripheral blood cells in all groups of experimental chicks ( Figure 5 ). MN test can measure subcellular processes of chromosomal breaks (clastogenesis) or cell spindle malfunctions (aneugenesis) as well as the formation of mitochondrial disruption and nuclear DNA than can lead to mitochondriadependent apoptosis in chicken embryos as an indicator of chromosomal damage [37] . Similar results were obtained in our current experiment that the MN and NA in peripheral blood erythrocytes were observed which has clearly demonstrating higher genotoxicity of high dose of L-Arg on the 8 th , 14 th and 18 th day incubation period. Moreover, 2T2 group showed no harmful effects at low doses of LArg (2T1 & 2T2) at 14 th day incubation time found normal architecture of nuclei in peripheral blood cells, similar to control group. 
Protein analysis by western blot
Western blot was performed in muscles to determine whether the different doses of L-Arg supplement at various days of incubation period may alter the protein levels of HSPs family such as HSP-47, HSP-60 and HSP-70. As shown in Figure (6) , the protein expressions of HSP-47, HSP-60 and HSP-70 were significantly down-regulated in the 2T1 group compared to other groups. Moreover, their levels in 3T2 and 3T3 groups were significantly up-regulated compared to 2T1 and 2T2 group, although protein expressions of HSP-60 and HSP-70 showed no significant difference among 1T1, 1T2, 1T3, and 2T1 groups. Moreover, HSP-46, HSP-60 and HSP-70 were down-regulated in 2T1 group compared to those in other groups whereas there was no significant difference in their levels between 1C and 2T1. HSP-70 is a reliable index of stress in chickens while "3-hydroxyl-3-methyl-glutaryl coenzyme A reductase" which has been used as an indicator of stress [38] . Pretreatment with L-Arg markedly reduced the dramatic down regulation of HSP-60 and HSP-70 in hypoxic rat model. The increased expression of HSP-60 and HSP-70 might be related to their leakages of tissue in response to tissue injury [39, 40] . Hence, present result may suggest that the increased level of HSP-47, HSP-60 and HSP70 in high doses of L-Arg may have the major role in tissue injury. The results of the study also show that the increase of HSP-60 and 70 may be involved in tissue injury in 3T1, 3T2, and 3T3 group. 2T1-group can prevent tissue injury via down-regulation of HSP-46, HSP-60 and HSP-70. Moreover, the protein expressions of myogenin and MyoD were significantly up-regulated in 2T1 group, whereas it was down regulated in 3T1, 3T2 and 3T3 groups compared to other experimental groups. Oxidative stress, can cause muscle atrophy by reducing myogenic differentiation markers such as Myogenin and MyoD in skeletal muscles [41] . Some growth factors, namely cytokines and oncogenes, suppress the activity of myogenin and MyoD, thus resulting in decreased in the mass of muscle which defined as muscle atrophy [42] . Previous study reported that myogenic regulatory factor mainly MyoD and MRF4 is only expressed later in different embryonic muscle groups [43] . Pro-oxidant compounds especially L-Arg are increased in muscle cell under oxidative stress and reduced-to-oxidized glutathione ratio, which suggests the impairment of myogenic regulatory factors such as Myogenin and MyoD. Not only that, results from the previous experiment demonstrated that L-Arg supplementation could promoted the HSP70 expression [44] . However, high concentration of branched chain amino acids, especially L-Arg can enhance expression of HSPs through whey protein hydrolysate [45] . Hence, our present study has proved that increasing the concentration of L-Arg at 8 th and 18 th day injection period could up-regulate the expression of HSP-60 and HSP-70 might be through whey protein hydrolysate that means improper of functional food ingredient. Moreover, the L-Arg at 14 th day with (100μg/100μl/egg) promote the muscle mass through up-regulation of MyoD and myogenin due to their free radical scavenging activity. 
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Measurement of IgM concentration in plasma
Concentrations of immune response markers such as IgM in all experimental group were analyzed. The duration and amount of L-Arg supplementation may influence immune status. Shortterm supplementary L-Arg can influence the immunity power because L-Arg has antioxidant and anti-inflammatory effects [46, 47] . It can attenuate inflammatory reactions by suppressing the generation of inflammatory mediators such as inflammatory cytokines and C-reactive protein which play a major role in the progression of tissue damage and organ dysfunction [48] . The treatment of L-Arg shows improved renal function through improve immune function [49] . Levels of IgM could provide an overall picture of immune function. It has been recently demonstrated that L-Arg can increase specific immune response against infectious bursal disease (IBD) in chickens [50] . L-Arg provided by treatment has been reported to be the sole precursor of nitric oxide with lots of immune functions and growth performance [51] . These same biological attributes might be present after low dose L-Arg injection on the 14 th day of incubation period. It may improve immunity via generation of IgM and suppression of inflammatory cytokines and C-reactive protein ( Figure 7 ). Figure 8 shows histology of liver of all experimental groups. Sections from the control group exhibited complete structure with regular shape of liver cells. Section from 1T1 and 2T1 shows normal hepatocyte gap compared to 1C and 1C1 group. Section from 1T3, 2T3, 3T1, 3T2, and 3T3 appears with intracytoplasmic vacuoles in hepatocytes around centrilobular regions. Moreover, hepatocyte tubes were surrounded by inflammatory cells and showed necrosis with nuclear fragmentation in 3T2 and 3T3 groups. The hepatocyte gap was increased in 2T3, 3T1, 3T2, and 3T3 groups. The hepatocyte gap appears in normal architecture in 1C, 1C1, 2C1, 3C1, 1T1, and 2T2. Degeneration of livers were observed for birds when treated with 167 and 334 mg/L of L-Arg had adverse effects on organs [52] . The liver after treatment with L-Arg (334mg/L) had congested vascular spaces and periportal mononuclear inflammatory infiltration [53] . Addition of L-Arg to poultry diets is required to avoid harmful influences of excessive free radicals produced during normal metabolism [54] . Dietary L-Arg supplementation plays a key role in enhancing meat quality. Increased L-Arg and betaine supplementation alleviates total body fat deposition and fatty liver [55, 56] . Additionally, supplementation with high doses (50 and 100%) of L-Arg has negative effects on the structure of the liver of Sasso birds proved by H&E staining. However, our current results showed that in ovo injection with low doses (2T1) of L-Arg on the 14 th day of egg embryo did not have any negative effects compared to higher doses of L-Arg on the 8 th or 18 th day of incubation period. 
Histopathology (H&E) staining
In silico molecular docking studies.
In silico molecular docking of L-Arg was studied. The entire glide, E model scores, and hydrogen bond interactions are presented in Table 1 . The main aim of the molecular modelling study is to understand interactions of functional groups present in L-Arg with residues of targeted proteins theoretically. In many of the cellular processes Heat shock protein 70 (Hsp70) involves the integral to protein homeostasis. Nearly, few of the human Hsp70 proteins are functioning through particular cellular compartments, such as endoplasmic reticulum, cytosol and mitochondria; they are expressed constitutively, though others are stress-induced. This stress-inducible human Hsp70 attracts the keen interest in cancer biology as stopping the construction of toxic protein aggregates that often happen in cancer cells, therefore, cancer cells errand the occurrence of Hsp70s for its survival. The solution structure of substrate binding domain (SBD) with the L542Y mutation, where the original sample of a human Hsp70 SBD structure in apo-form. The SBD is divided into an N-terminal β-sheet (SBDβ) and a C-terminal α-helical subdomain (SBDα) providing an elastic lid of SBDβ. Thus, the protein, solution structure for human HSP70 substrate binding domain L542Y mutant (PDB id: 5XIR) were selected for the in silico molecular modelling study with L-arginine [57] . 
Conclusion
In this study, we described a suitable embryonic developmental stage for accessibility of in ovo injection using L-Arg at different concentrations for the first time. The 14 th day injection of L-Arg at 100 μg/μl/egg enhanced both hatching and survival rates. It also increased body weight and immune response (IgM). Histology from control and 2T1 groups sowed normal architecture while injection on the 18 th day of incubation of 1 st day chicks showed liver tissue damage. Overall results demonstrate that the optimum dose is 100μg/μl/egg and optimum injection stage is 14 th day to improve the immunity, hatching, and survival rate which can be used for the poultry industry. In ovo injection in early and late embryonic stages could not offer good benefit for survival, hatching rate, or muscle development. If we choose middle stage of embryonic development for in ovo injection, L-Arg might be able to promote muscle growth and improve the immune power without inducing adverse effect on the liver.
